Assembly Biosciences, Inc.
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Mar 2017 | $66.4M | $134.3M | $70.8M |
| Jun 2017 | $66.2M | $122.8M | $39.5M |
| Sep 2017 | $65.2M | $112.3M | $27.2M |
| Dec 2017 | $56.2M | $169.3M | $82.0M |
| Mar 2018 | $53.6M | $156.0M | $66.9M |
| Jun 2018 | $53.3M | $142.4M | $54.2M |
| Sep 2018 | $53.5M | $283.0M | $119.8M |
| Dec 2018 | $57.4M | $268.0M | $41.5M |
| Mar 2019 | $68.8M | $259.2M | $29.1M |
| Jun 2019 | $66.8M | $241.5M | $34.3M |
| Sep 2019 | $66.9M | $223.3M | $24.9M |
| Dec 2019 | $66.7M | $339.9M | $46.7M |
| Mar 2020 | $61.5M | $313.3M | $42.3M |
| Jun 2020 | $27.7M | $294.8M | $96.7M |
| Sep 2020 | $35.8M | $306.3M | $58.3M |
| Dec 2020 | $42.7M | $283.3M | $59.4M |
| Mar 2021 | $31.7M | $278.9M | $78.3M |
| Jun 2021 | $30.3M | $262.1M | $59.5M |
| Sep 2021 | $24.3M | $249.0M | $70.8M |
| Dec 2021 | $22.1M | $191.1M | $45.6M |
| Mar 2022 | $15.9M | $162.7M | $51.2M |
| Jun 2022 | $19.5M | $143.4M | $43.1M |
| Sep 2022 | $19.1M | $121.5M | $54.7M |
| Dec 2022 | $19.1M | $101.8M | $52.4M |
| Mar 2023 | $12.8M | $83.1M | $43.5M |
| Jun 2023 | $11.6M | $66.6M | $21.6M |
| Sep 2023 | $9.9M | $51.6M | $26.7M |
| Dec 2023 | $95.7M | $136.8M | $19.8M |
| Mar 2024 | $87.3M | $119.9M | $18.7M |
| Jun 2024 | $80.6M | $115.3M | $19.2M |
| Sep 2024 | $74.3M | $100.3M | $28.5M |
| Dec 2024 | $85.8M | $119.2M | $38.3M |
| Mar 2025 | $71.9M | $99.0M | $23.4M |
| Jun 2025 | $62.7M | $80.8M | $24.0M |
| Sep 2025 | $57.3M | $240.0M | $22.5M |
| Dec 2025 | $50.8M | $257.6M | $58.5M |
| Mar 2026 | $36.9M | $235.5M | $31.1M |
| Jun 2026 | $25.2M | $330.8M | $32.3M |